J 2021

Consistent B Cell Receptor Immunoglobulin Features Between Siblings in Familial Chronic Lymphocytic Leukemia

KOLIJN, P.M.; A.F. MUGGEN; V. LJUNGSTROM; A. AGATHANGELIDIS; I.L.M. WOLVERS-TETTERO et al.

Základní údaje

Originální název

Consistent B Cell Receptor Immunoglobulin Features Between Siblings in Familial Chronic Lymphocytic Leukemia

Autoři

KOLIJN, P.M.; A.F. MUGGEN; V. LJUNGSTROM; A. AGATHANGELIDIS; I.L.M. WOLVERS-TETTERO; H.B. BEVERLOO; Karol PÁL; P.J. HENGEVELD; N. DARZENTAS; R.W. HENDRIKS; J.J.M. VAN DONGEN; R. ROSENQUIST a A.W. LANGERAK

Vydání

Frontiers in Oncology, Lausanne, Frontiers Media S.A. 2021, 2234-943X

Další údaje

Jazyk

angličtina

Typ výsledku

Článek v odborném periodiku

Obor

30204 Oncology

Stát vydavatele

Švýcarsko

Utajení

není předmětem státního či obchodního tajemství

Odkazy

Impakt faktor

Impact factor: 5.738

Označené pro přenos do RIV

Ano

Kód RIV

RIV/00216224:14740/21:00124302

Organizační jednotka

Středoevropský technologický institut

EID Scopus

Klíčová slova anglicky

CLL (Chronic Lymphocytic Leukemia); Familial CLL; BCR stereotypy; IGLV3-21 R110; CLL development

Štítky

Příznaky

Mezinárodní význam, Recenzováno
Změněno: 26. 2. 2022 14:05, Mgr. Pavla Foltynová, Ph.D.

Anotace

V originále

Key processes in the onset and evolution of chronic lymphocytic leukemia (CLL) are thought to include chronic (antigenic) activation of mature B cells through the B cell receptor (BcR), signals from the microenvironment, and acquisition of genetic alterations. Here we describe three families in which two or more siblings were affected by CLL. We investigated whether there are immunogenetic similarities in the leukemia-specific immunoglobulin heavy (IGH) and light (IGL/IGK) chain gene rearrangements of the siblings in each family. Furthermore, we performed array analysis to study if similarities in CLL-associated chromosomal aberrations are present within each family and screened for somatic mutations using paired tumor/normal whole-genome sequencing (WGS). In two families a consistent IGHV gene mutational status (one IGHV-unmutated, one IGHV-mutated) was observed. Intriguingly, the third family with four affected siblings was characterized by usage of the lambda IGLV3-21 gene, with the hallmark R110 mutation of the recently described clinically aggressive IGLV3-21(R110) subset. In this family, the CLL-specific rearrangements in two siblings could be assigned to either stereotyped subset #2 or the immunogenetically related subset #169, both of which belong to the broader IGLV3-21(R110) subgroup. Consistent patterns of cytogenetic aberrations were encountered in all three families. Furthermore, the CLL clones carried somatic mutations previously associated with IGHV mutational status, cytogenetic aberrations and stereotyped subsets, respectively. From these findings, we conclude that similarities in immunogenetic characteristics in familial CLL, in combination with genetic aberrations acquired, point towards shared underlying mechanisms behind CLL development within each family.